View:
Download DOC
Download PDF
Download XLS
Filed by Bowne Pure Compliance
     
 
OMB APPROVAL
  
 
OMB Number: 3235-0145
  
 
Expires: February 28, 2009
  
 
Estimated average burden hours per response...10.4
  
 
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. 6)*

Integra LifeSciences Holdings Corporation
(Name of Issuer)
Common stock, $.01 par value
(Title of Class of Securities)
457985208
(CUSIP Number)
December 31, 2008
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     o Rule 13d-1(b)

     o Rule 13d-1(c)

     þ Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 

 

                     
CUSIP No.
  
457985208  
   Page  
2 
   of   
9 

 

           
1   NAMES OF REPORTING PERSONS

Richard E. Caruso, Ph.D.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)   þ
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  5   SOLE VOTING POWER
     
NUMBER OF   85,591 shares*
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   6,633,543*
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   85,591*
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    6,633,543*
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  6,719,134 shares*
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  24.3%*
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
*Includes 47,520 shares of common stock that may be acquired upon exercise of options as of or within 60 days of February 1, 2009. Dr. Caruso disclaims beneficial ownership of the shares owned by Tru St Partnership LP, Provco Leasing Corporation and The Uncommon Individual Foundation as described in this Schedule 13G (Amendment No. 6) except to the extent of his pecuniary interest therein.

 

                     
CUSIP No.
  
457985208  
   Page  
3 
   of   
9 

 

           
1   NAMES OF REPORTING PERSONS

Tru St Partnership LP
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)   þ
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Pennsylvania
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   6,591,205 shares
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    6,591,205 shares
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  6,591,205 shares
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  23.8%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN

 

                     
CUSIP No.
  
457985208  
   Page  
4 
   of   
9 

 

           
1   NAMES OF REPORTING PERSONS

Provco Leasing Corporation
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)   þ
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   6,614,543 shares
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    6,614,543 shares
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  6,614,543 shares
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  23.9%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  CO

 

                     
CUSIP No.
  
457985208  
   Page  
5 
   of   
9 

 

           
1   NAMES OF REPORTING PERSONS

The Uncommon Individual Foundation
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)   þ
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Pennsylvania
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   19,000 shares
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    19,000 shares
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  19,000 shares
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0.069%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  CO

 

                     
 
  
 
   Page  
6 
   of   
9 
Item 1.
  (a)   Name of Issuer: Integra LifeSciences Holdings Corporation
 
  (b)   Address of Issuer’s Principal Executive Offices: 311 Enterprise Drive, Plainsboro, New Jersey 08536
Item 2.
  (a)   Name of Person Filing: See (c) below.
 
  (b)   Address of Principal Business Office or, if none, Residence: See (c) below.
 
  (c)   Citizenship:
Richard E. Caruso Ph.D.
795 East Lancaster Ave., Suite 200
Villanova, Pennsylvania 19085
United States citizen
Tru St Partnership LP
795 East Lancaster Ave, Suite 200
Villanova, Pennsylvania 19085
Pennsylvania limited partnership
Provco Leasing Corporation
1105 N. Market Street. Suite 602
Wilmington, Delaware 19810
Delaware corporation
The Uncommon Individual Foundation
795 East Lancaster Ave, Suite 204
Villanova, Pennsylvania 19085
Pennsylvania corporation
  (d)   Title of Class of Securities: common stock, $.01 par value.
 
  (e)   CUSIP Number: 457985208
Item 3. Not applicable.
Item 4.  Ownership: Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
  (a)   Amount beneficially owned: As of December 31, 2008, Dr. Caruso may be deemed the beneficial owner of 6,719,134 shares of common stock. He individually holds 38,071 shares and holds options to purchase 47,520 shares of common stock that are exercisable within 60 days of February 1, 2009. Tru St Partnership LP (“Tru St”) may be deemed the beneficial owner of 6,591,205 shares of common stock. Dr. Caruso is the president and sole director of Provco Leasing Corporation (‘Provco Leasing”). Provco Leasing is the corporate general partner of Tru St. Provco Leasing is also the beneficial owner of 23,338 shares of common stock. The Uncommon Individual Foundation is the beneficial owner of 19,000 shares of common stock. Dr. Caruso is the founder and chief executive officer of The Uncommon Individual Foundation. Dr. Caruso disclaims beneficial ownership of shares held by Tru St, Provco Leasing and The Uncommon Individual Foundation except to the extent of his pecuniary interest therein.

 

 

 

                     
 
  
 
   Page  
7 
   of   
9 
  (b)   Percent of Class: Based on 27,645,284 shares of the Issuer’s common stock outstanding as of November 5, 2008 as reported in the Issuer’s Form 10-Q for the quarter ended September 30, 2008: Dr. Caruso may be deemed the beneficial owner of 24.3% of the Issuer’s common stock; Tru St, may be deemed the beneficial owner of 23.8% of the Issuer’s common stock; Provco Leasing may be deemed the beneficial owner of 23.9% of the Issuer’s common stock and The Uncommon Individual Foundation may be deemed the beneficial owner of 0.069% of the Issuer’s common stock.
 
  (c)   The Reporting Persons have the power to vote or dispose of the number of shares as follows:
  (i)   Sole power to vote or direct the vote. Dr. Caruso may be deemed to have sole power to vote or direct the vote of 85,591 shares of common stock based on his ownership of 38,071 shares and options to purchase 47,520 shares of common stock that are exercisable within 60 days of February 1, 2009.
 
  (ii)   Shared power to vote or direct the vote. Dr. Caruso, Tru St, Provco Leasing and The Uncommon Individual Foundation may be deemed to share the power to vote or direct the vote with respect to 6,633,543 shares of common stock. Dr. Caruso and Tru St may be deemed to share the power to vote or direct the vote with respect to 6,591,205 shares of common stock. Dr. Caruso and Provco Leasing may be deemed to share the power to vote or direct the vote with respect to 6,614,543 shares of common stock. Dr. Caruso and The Uncommon Individual Foundation may be deemed to share the power to vote or direct the vote with respect to 19,000 shares of common stock.
 
  (iii)   Sole power to dispose or direct the disposition. Dr. Caruso has sole power to dispose or control the disposition of 85,591 shares of common stock based on his ownership of 38,071 shares and options to purchase 47,520 shares of common stock that are exercisable within 60 days of February 1, 2009.
 
  (iv)   Shared power to dispose or direct the disposition. Dr. Caruso, Tru St Provco Leasing and The Uncommon Individual Foundation may be deemed to have shared power to dispose of or shared power to direct the disposition of 6,633,543 shares of common stock. Dr. Caruso and Tru St may be deemed to have shared power to dispose of or shared power to direct the disposition of 6,591,205 shares of common stock. Dr. Caruso and Provco Leasing may be deemed to have shared power to dispose of or shared power to direct the disposition of 6,614,543 shares of common stock. Dr. Caruso and The Uncommon Individual Foundation may be deemed to have shared power to dispose of or direct the disposition of 19,000 shares of common stock.

 

 

 

                     
 
  
 
   Page  
8 
   of   
9 
Item 5. Ownership of Five Percent or less of a Class:
Not applicable.
Item 6. Ownership of More Than Five Percent on Behalf of Another Person:
Not applicable.
Item 7.  Identification and Classification of the Subsidiary which Acquired the Security Reported on by the Parent Holding Company:
Not applicable.
Item 8. Identification and Classification of Members of the Group:
Exhibit A attached hereto identifies each member of the group filing this Schedule 13G/A pursuant to Rule 13d-1(c).
Item 9. Notice of Dissolution of Group:
Not applicable.
Item 10. Certification:
Not applicable.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
         
Date: January 31, 2009  /s/ Richard E. Caruso    
  Richard E. Caruso, Ph.D.   
         
TRU ST PARTNERSHIP LP    
 
        
By:
  /s/ Richard E. Caruso    
 
  Its: President    
 
        
PROVCO LEASING CORPORATION    
 
        
By:
  /s/ Richard E. Caruso    
 
  Its: President    
 
        
THE UNCOMMON INDIVIDUAL FOUNDATION    
 
        
By:
  /s/ Richard E. Caruso    
 
  Its: President    

 

 

 

                     
 
  
 
   Page  
9 
   of   
9 
Exhibit Index
             
Exhibit   Title   Page No.  
 
            
Exhibit A
  Group Members        
 
            
Exhibit B
  Joint Filing Agreement        

 

 

Filed by Bowne Pure Compliance
EXHIBIT A
Group Members
Richard E. Caruso, Ph.D.
Tru St Partnership LP
Provco Leasing Corporation
The Uncommon Individual Foundation

 

 

Filed by Bowne Pure Compliance
EXHIBIT B
Joint Filing Agreement
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G/A (including amendments thereto) with respect to the common stock, par value $.01 per share of Integra LifeSciences Holdings Corporation, and further agree that this Joint Filing Agreement be included as Exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, have executed this Joint Filing Agreement this 31 day of January 2009.
                     
TRU ST PARTNERSHIP LP                
 
                    
By:
  /s/ Richard E. Caruso       By:   /s/ Richard E. Caruso    
 
  Its: President           Richard E. Caruso, Ph.D.    
 
                    
PROVCO LEASING CORPORATION                
 
                    
By:
  /s/ Richard E. Caruso                
 
  Its: President                
 
                    
THE UNCOMMON INDIVIDUAL FOUNDATION            
 
                    
By:
  /s/ Richard E. Caruso                
 
  Its: President